实用心脑肺血管病杂志
實用心腦肺血管病雜誌
실용심뇌폐혈관병잡지
PRACTICAL JOURNAL OF CARDIAC CEREBRAL PNEUMAL AND VASCULAR DISEASE
2014年
9期
25-26
,共2页
才江平%曲娜%马佑平%张桐%徐慧慧%伊娟
纔江平%麯娜%馬祐平%張桐%徐慧慧%伊娟
재강평%곡나%마우평%장동%서혜혜%이연
肺疾病,慢性阻塞性%穴位,背部%治疗结果
肺疾病,慢性阻塞性%穴位,揹部%治療結果
폐질병,만성조새성%혈위,배부%치료결과
Pulmonary disease,chronic obstructive%POINTS,BACK OF TRUNK%Treatment outcome
目的:探讨背部腧穴药物注射治疗慢性阻塞性肺疾病急性加重期患者的临床疗效。方法选取我院2008-2012年收治的慢性阻塞性肺疾病急性加重期患者360例,随机分为 A、B、C 3组,每组120例。3组患者入院后均进行常规治疗,A 组患者给予决明茶碱、薯芋皂甙、莨菪碱溶液2 ml 背部腧穴注射,B 组患者给予决明茶碱、薯芋皂甙、莨菪碱溶液2 ml 肌肉注射,C 组患者给予二丙茶碱0.5 g ﹢甲泼尼龙40 mg ﹢0.9%氯化钠溶液250 ml 静脉滴注。观察3组患者起效时间、临床疗效、治疗前及治疗30 min 后肺功能。结果 A 组患者起效时间为5~15 min,B 组为30~45 min,C 组为20~30 min。A 组患者总有效率为97.5%,B 组为56.7%,C 组为93.3%,A、C 组患者总有效率均高于 B 组(P ﹤0.05),而 A 组与 C 组总有效率比较,差异无统计学意义(P ﹥0.05)。3组患者治疗前用力肺活量(FVC)、用力呼气量(FEV)及最大呼气中期流量(MMEF)比较,差异均无统计学意义(P ﹥0.05);治疗后,A 组患者 FVC、FEV、MMEF 大于 B 组(P ﹤0.05),而 A 组与 C 组、B 组与 C 组 FVC、FEV、MMEF 比较,差异均无统计学意义(P ﹥0.05)。结论背部腧穴药物注射治疗慢性阻塞性肺疾病急性加重期患者起效快,作用迅速,可有效改善其肺功能,缓解其临床症状,临床疗效较好,安全性较高。
目的:探討揹部腧穴藥物註射治療慢性阻塞性肺疾病急性加重期患者的臨床療效。方法選取我院2008-2012年收治的慢性阻塞性肺疾病急性加重期患者360例,隨機分為 A、B、C 3組,每組120例。3組患者入院後均進行常規治療,A 組患者給予決明茶堿、藷芋皂甙、莨菪堿溶液2 ml 揹部腧穴註射,B 組患者給予決明茶堿、藷芋皂甙、莨菪堿溶液2 ml 肌肉註射,C 組患者給予二丙茶堿0.5 g ﹢甲潑尼龍40 mg ﹢0.9%氯化鈉溶液250 ml 靜脈滴註。觀察3組患者起效時間、臨床療效、治療前及治療30 min 後肺功能。結果 A 組患者起效時間為5~15 min,B 組為30~45 min,C 組為20~30 min。A 組患者總有效率為97.5%,B 組為56.7%,C 組為93.3%,A、C 組患者總有效率均高于 B 組(P ﹤0.05),而 A 組與 C 組總有效率比較,差異無統計學意義(P ﹥0.05)。3組患者治療前用力肺活量(FVC)、用力呼氣量(FEV)及最大呼氣中期流量(MMEF)比較,差異均無統計學意義(P ﹥0.05);治療後,A 組患者 FVC、FEV、MMEF 大于 B 組(P ﹤0.05),而 A 組與 C 組、B 組與 C 組 FVC、FEV、MMEF 比較,差異均無統計學意義(P ﹥0.05)。結論揹部腧穴藥物註射治療慢性阻塞性肺疾病急性加重期患者起效快,作用迅速,可有效改善其肺功能,緩解其臨床癥狀,臨床療效較好,安全性較高。
목적:탐토배부수혈약물주사치료만성조새성폐질병급성가중기환자적림상료효。방법선취아원2008-2012년수치적만성조새성폐질병급성가중기환자360례,수궤분위 A、B、C 3조,매조120례。3조환자입원후균진행상규치료,A 조환자급여결명다감、서우조대、랑탕감용액2 ml 배부수혈주사,B 조환자급여결명다감、서우조대、랑탕감용액2 ml 기육주사,C 조환자급여이병다감0.5 g ﹢갑발니룡40 mg ﹢0.9%록화납용액250 ml 정맥적주。관찰3조환자기효시간、림상료효、치료전급치료30 min 후폐공능。결과 A 조환자기효시간위5~15 min,B 조위30~45 min,C 조위20~30 min。A 조환자총유효솔위97.5%,B 조위56.7%,C 조위93.3%,A、C 조환자총유효솔균고우 B 조(P ﹤0.05),이 A 조여 C 조총유효솔비교,차이무통계학의의(P ﹥0.05)。3조환자치료전용력폐활량(FVC)、용력호기량(FEV)급최대호기중기류량(MMEF)비교,차이균무통계학의의(P ﹥0.05);치료후,A 조환자 FVC、FEV、MMEF 대우 B 조(P ﹤0.05),이 A 조여 C 조、B 조여 C 조 FVC、FEV、MMEF 비교,차이균무통계학의의(P ﹥0.05)。결론배부수혈약물주사치료만성조새성폐질병급성가중기환자기효쾌,작용신속,가유효개선기폐공능,완해기림상증상,림상료효교호,안전성교고。
Objective To investigate the clinical effect of back acupoint injection on acute exacerbation of chronic ob-structive pulmonary disease. Methods From 2008 to 2012,a total of 360 patients with acute exacerbation of chronic obstructive pulmonary disease were selected,and then they were randomly divided into groups A,B,C,120 cases in each. All patients given routine treatment after admission,and then A group given back acupoint injection(2 ml solution of cassia tora theophylline﹢ potato taro saponins ﹢ hyoscyamine),B group given muscle injection(2 ml solution of cassia tora theophylline ﹢ potato taro saponins ﹢ hyoscyamine),C group given intravenous drip(dipropyl theophylline 0. 5 g ﹢ methylprednisolone 40 mg ﹢ 0. 9% so-dium chloride solution 250 ml). Onset time,clinical effect,lung function before treatment and 30 minutes after treatment of the three groups were observed. Results The onset time of A group was 5 to 15 minutes,that of B group was 30 to 45 minutes,that of C group was 20 to 30 minutes. The total effective rate of A group was 97. 5% ,that of B group was 56. 7% ,that of C group was 93. 3% ,the total effective rate of A group and C group was higher than that of B group(P ﹤ 0. 05),while there was no sig-nificant difference between groups A and C(P ﹥ 0. 05). There was no significant difference of FVC,FEV and MMEF in the three groups before treatment;after treatment,FVC,FEV and MMEF of A group were higher than those of B group( P ﹤0. 05),while those between groups A and C,groups B and C was not statistically different(P ﹥ 0. 05). Conclusion Back acupoint injection has certain effect on acute exacerbation of chronic obstructive pulmonary disease,its onset time is short,can effectively improve the lung function,relief the clinical symptoms,and is safe.